Jianpi Huayu decoction alleviates hepatic fibrosis involving coordinated modulation of PPARα-mediated lipid metabolic reprogramming and the ROCK pathway
Authors:
- Rui LuoRLRui Luo
- Ruiwei YaoRYRuiwei Yao
- Hanhan LiHLHanhan Li
- Xinqiu ChenXCXinqiu Chen
- Chong ZhongCZChong Zhong
- 25 June 2026
- journal article
- Published by Elsevier in Phytomedicine
- Vol. 159, 158496
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China
This publication has 26 references indexed in Scilit:
- Selective targeting of endothelial and perivascular angiocrine ROCK2 treats liver fibrosisCell, 2026
- Hepatitis B Virus Treatment Gaps in the USJAMA Network Open, 2025
- Chromatin remodeler BRD9 represses transcription of PPARα target genes, including CPT1A to suppress lipid metabolismJournal of Lipid Research, 2025
- Recent Advances in the Investigation of the Role and Immunoregulatory Mechanisms of Polysaccharides From Traditional Chinese Medicine in the Intervention of Liver CirrhosisPhytotherapy Research, 2025
- Hepatic Stellate Cell TM4SF1 Accelerates Hepatic Fibrosis Progression via Interacting With the Tyrosine Kinase c-SrcCellular and Molecular Gastroenterology and Hepatology, 2025
- Efficacy and safety of time-restricted eating in metabolic dysfunction-associated steatotic liver diseaseJournal of Hepatology, 2025
- Vitamin D receptor attenuates carbon tetrachloride-induced liver fibrosis via downregulation of YAPJournal of Hazardous Materials, 2024
- Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antiviralsCurrent Opinion in Virology, 2024
- High-risk population of progressive hepatic fibrosis in chronic hepatitis B patients on antiviral therapyJournal of Gastroenterology, 2023
- Jianpi Huayu decoction inhibits the epithelial–mesenchymal transition of hepatocellular carcinoma cells by suppressing exosomal miR-23a-3p/Smad signalingJournal of Ethnopharmacology, 2022